Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats

Detalhes bibliográficos
Autor(a) principal: Minhos, Liandra Ferreira
Data de Publicação: 2023
Outros Autores: de Lima Gehlen, Ana Cláudia da Silva [UNESP], Júnior, Felipe Francisco Bittencourt, Dos Santos, Ariany Carvalho, Souza, Roosevelt Isaias Carvalho, de Barros, Márcio Eduardo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.2174/1389201023666220429121953
http://hdl.handle.net/11449/246806
Resumo: Background: Hemorrhagic cystitis is an inflammatory complication that can be caused by the administration of cyclophosphamide, which is widely used as an antineoplastic agent. In the search for new therapeutic alternatives, probiotics can suppress the inflammatory process and, there-fore, can be used to prevent this disease. Objective: Thus, this study aimed to evaluate the effects of using Lactobacillus acidophilus NCFM in the treatment of cyclophosphamide-induced hemorrhagic cystitis in Wistar rats. Methods: Lactobacillus acidophilus NCFM (2x108 CFU) was used in the treatment of cyclophos-phamide-induced hemorrhagic cystitis (200 mg/kg, intraperitoneal) in 77 female Wistar rats. Rats were distributed into experimental groups (n = 9): control group (GC), zero control group (GCZ), inflammation group (GI), 24-hour acute treatment groups: 24-hour lactobacilli treatment group (GL24H) and mesna group (GM), and 30-day chronic treatment groups: lactobacilli treatment group (GTL) and mesna+lactobacilli group (GM+L). After treatment, animals were euthanized and biological materials were collected for blood count, biochemical analyses, examination of abnormal sedi-ment elements (EAS), and histopathological analysis. Results: GI results showed development of edema, macroscopic alterations, and signs of bleeding in the bladder; in addition, lesions in the urothelium and hemorrhage were also found. GL24H and GM presented intact urothelium, without inflammatory reaction and hematological or biochemical urine alterations. Conclusion: Therefore, this study demonstrated that L. acidophilus presented uroprotective effect against the action of cyclophosphamide in both the short and long term.
id UNSP_a439a82e7d951f7e68e5d9cb7a573ae9
oai_identifier_str oai:repositorio.unesp.br:11449/246806
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Ratsbladder inflammationcyclophosphamideHemorrhagic cystitisLactobacillus sppprobioticswistar ratsBackground: Hemorrhagic cystitis is an inflammatory complication that can be caused by the administration of cyclophosphamide, which is widely used as an antineoplastic agent. In the search for new therapeutic alternatives, probiotics can suppress the inflammatory process and, there-fore, can be used to prevent this disease. Objective: Thus, this study aimed to evaluate the effects of using Lactobacillus acidophilus NCFM in the treatment of cyclophosphamide-induced hemorrhagic cystitis in Wistar rats. Methods: Lactobacillus acidophilus NCFM (2x108 CFU) was used in the treatment of cyclophos-phamide-induced hemorrhagic cystitis (200 mg/kg, intraperitoneal) in 77 female Wistar rats. Rats were distributed into experimental groups (n = 9): control group (GC), zero control group (GCZ), inflammation group (GI), 24-hour acute treatment groups: 24-hour lactobacilli treatment group (GL24H) and mesna group (GM), and 30-day chronic treatment groups: lactobacilli treatment group (GTL) and mesna+lactobacilli group (GM+L). After treatment, animals were euthanized and biological materials were collected for blood count, biochemical analyses, examination of abnormal sedi-ment elements (EAS), and histopathological analysis. Results: GI results showed development of edema, macroscopic alterations, and signs of bleeding in the bladder; in addition, lesions in the urothelium and hemorrhage were also found. GL24H and GM presented intact urothelium, without inflammatory reaction and hematological or biochemical urine alterations. Conclusion: Therefore, this study demonstrated that L. acidophilus presented uroprotective effect against the action of cyclophosphamide in both the short and long term.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Department of Health Sciences Faculty of Health Sciences Federal University of Grande Dourados (UFGD)Department of structural and functional biology Faculty of General and Applied Biology “Julio de Mesquita Filho” São Paulo State University (UNESP)Department of Clinical Biochemistry Faculty of Biomedicine University Center of Grande Dourados (UNIGRAN)Department of structural and functional biology Faculty of General and Applied Biology “Julio de Mesquita Filho” São Paulo State University (UNESP)Federal University of Grande Dourados (UFGD)Universidade Estadual Paulista (UNESP)University Center of Grande Dourados (UNIGRAN)Minhos, Liandra Ferreirade Lima Gehlen, Ana Cláudia da Silva [UNESP]Júnior, Felipe Francisco BittencourtDos Santos, Ariany CarvalhoSouza, Roosevelt Isaias Carvalhode Barros, Márcio Eduardo2023-07-29T12:51:00Z2023-07-29T12:51:00Z2023-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article438-449http://dx.doi.org/10.2174/1389201023666220429121953Current Pharmaceutical Biotechnology, v. 24, n. 3, p. 438-449, 2023.1873-43161389-2010http://hdl.handle.net/11449/24680610.2174/13892010236662204291219532-s2.0-85147823676Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengCurrent Pharmaceutical Biotechnologyinfo:eu-repo/semantics/openAccess2023-07-29T12:51:00Zoai:repositorio.unesp.br:11449/246806Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T15:49:42.489283Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
title Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
spellingShingle Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
Minhos, Liandra Ferreira
bladder inflammation
cyclophosphamide
Hemorrhagic cystitis
Lactobacillus spp
probiotics
wistar rats
title_short Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
title_full Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
title_fullStr Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
title_full_unstemmed Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
title_sort Evaluation of the Efficacy of Lactobacillus acidophilus in the Treatment of Cyclophosphamide-induced Hemorrhagic Cystitis in Wistar Rats
author Minhos, Liandra Ferreira
author_facet Minhos, Liandra Ferreira
de Lima Gehlen, Ana Cláudia da Silva [UNESP]
Júnior, Felipe Francisco Bittencourt
Dos Santos, Ariany Carvalho
Souza, Roosevelt Isaias Carvalho
de Barros, Márcio Eduardo
author_role author
author2 de Lima Gehlen, Ana Cláudia da Silva [UNESP]
Júnior, Felipe Francisco Bittencourt
Dos Santos, Ariany Carvalho
Souza, Roosevelt Isaias Carvalho
de Barros, Márcio Eduardo
author2_role author
author
author
author
author
dc.contributor.none.fl_str_mv Federal University of Grande Dourados (UFGD)
Universidade Estadual Paulista (UNESP)
University Center of Grande Dourados (UNIGRAN)
dc.contributor.author.fl_str_mv Minhos, Liandra Ferreira
de Lima Gehlen, Ana Cláudia da Silva [UNESP]
Júnior, Felipe Francisco Bittencourt
Dos Santos, Ariany Carvalho
Souza, Roosevelt Isaias Carvalho
de Barros, Márcio Eduardo
dc.subject.por.fl_str_mv bladder inflammation
cyclophosphamide
Hemorrhagic cystitis
Lactobacillus spp
probiotics
wistar rats
topic bladder inflammation
cyclophosphamide
Hemorrhagic cystitis
Lactobacillus spp
probiotics
wistar rats
description Background: Hemorrhagic cystitis is an inflammatory complication that can be caused by the administration of cyclophosphamide, which is widely used as an antineoplastic agent. In the search for new therapeutic alternatives, probiotics can suppress the inflammatory process and, there-fore, can be used to prevent this disease. Objective: Thus, this study aimed to evaluate the effects of using Lactobacillus acidophilus NCFM in the treatment of cyclophosphamide-induced hemorrhagic cystitis in Wistar rats. Methods: Lactobacillus acidophilus NCFM (2x108 CFU) was used in the treatment of cyclophos-phamide-induced hemorrhagic cystitis (200 mg/kg, intraperitoneal) in 77 female Wistar rats. Rats were distributed into experimental groups (n = 9): control group (GC), zero control group (GCZ), inflammation group (GI), 24-hour acute treatment groups: 24-hour lactobacilli treatment group (GL24H) and mesna group (GM), and 30-day chronic treatment groups: lactobacilli treatment group (GTL) and mesna+lactobacilli group (GM+L). After treatment, animals were euthanized and biological materials were collected for blood count, biochemical analyses, examination of abnormal sedi-ment elements (EAS), and histopathological analysis. Results: GI results showed development of edema, macroscopic alterations, and signs of bleeding in the bladder; in addition, lesions in the urothelium and hemorrhage were also found. GL24H and GM presented intact urothelium, without inflammatory reaction and hematological or biochemical urine alterations. Conclusion: Therefore, this study demonstrated that L. acidophilus presented uroprotective effect against the action of cyclophosphamide in both the short and long term.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-29T12:51:00Z
2023-07-29T12:51:00Z
2023-01-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.2174/1389201023666220429121953
Current Pharmaceutical Biotechnology, v. 24, n. 3, p. 438-449, 2023.
1873-4316
1389-2010
http://hdl.handle.net/11449/246806
10.2174/1389201023666220429121953
2-s2.0-85147823676
url http://dx.doi.org/10.2174/1389201023666220429121953
http://hdl.handle.net/11449/246806
identifier_str_mv Current Pharmaceutical Biotechnology, v. 24, n. 3, p. 438-449, 2023.
1873-4316
1389-2010
10.2174/1389201023666220429121953
2-s2.0-85147823676
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Current Pharmaceutical Biotechnology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 438-449
dc.source.none.fl_str_mv Scopus
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128569560268800